Ingrid Olsen
Medical · Castle Dale, UTNPI 1326233610
Payments from drug & device makers
Across 118 payments — averaging $17.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$778
- AstraZeneca$483
- Mylan Specialty L.p.$126
- Lilly USA, LLC$113
- Biohaven Pharmaceutical Holding Company Ltd.$77
- Boehringer Ingelheim$76
- plus $443 from 14 others
What the payments were for
- Food & beverage$2,095100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 44 | $778 |
| AstraZeneca | 28 | $483 |
| Mylan Specialty L.p. | 7 | $126 |
| Lilly USA, LLC | 7 | $113 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $77 |
| Boehringer Ingelheim | 5 | $76 |
| Myriad Women's Health, Inc. | 1 | $71 |
| Pfizer | 4 | $68 |
| Axsome Therapeutics, Inc. | 4 | $60 |
| Amgen | 3 | $53 |
| Novo Nordisk | 2 | $30 |
| Novartis | 1 | $24 |
| Abbott | 1 | $22 |
| Exact Sciences | 1 | $21 |
| Organon | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
| Bayer | 1 | $15 |
| Antares Pharma, Inc. | 1 | $14 |
| Merck | 1 | $13 |
How this compares
$2,095 in reported general payments places this provider in the 65th percentile of 263 medical providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 13 | $93,530 |
| MounjaroTirzepatide | 51 | $55,783 |
| TrulicityDulaglutide | 42 | $49,617 |
| OzempicSemaglutide | 29 | $37,015 |
| EliquisApixaban | 29 | $26,853 |
| Invega SustennaPaliperidone Palmitate | 13 | $25,040 |
| JardianceEmpagliflozin | 31 | $24,811 |
| VraylarCariprazine Hcl | 16 | $23,422 |
| FarxigaDapagliflozin Propanediol | 20 | $17,238 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $12,366 |
| XareltoRivaroxaban | 13 | $12,103 |
| Tresiba Flextouch U-100Insulin Degludec | 14 | $11,823 |
| TrintellixVortioxetine Hydrobromide | 15 | $10,449 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $7,330 |
| Breo ElliptaFluticasone/Vilanterol | 15 | $5,798 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $113 | $105,40093 claims |
| Novo NordiskOzempic | $30 | $37,01529 claims |
| PfizerEliquis | $68 | $26,85329 claims |
| Boehringer IngelheimJardiance | $76 | $24,81131 claims |
| AbbVieVraylar | $778 | $23,42216 claims |
| AstraZenecaFarxiga | $483 | $17,23820 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 263 medical providers in Utah.
Other medical in Castle Dale
- Elisa WilcoxSalt Lake City$178K
- Viet leSalt Lake City$65K
- Val WarnerLayton$51K
- Carmelo DiazSalt Lake City$35K
- Shari CombeSalt Lake City$22K
- Kelly MikesellOgden$19K
- Jennifer CoombsSlc$12K
- Brandon HansenRiverton$10K
- Daniel CorryCedar City$10K
- Mark UdySt George$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.